Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Selected Area Electron Beam Induced Deposition of Pt and W for EBSD Backgrounds.

Osborn WA, McLean MJ, Bush B.

Microsc Microanal. 2019 Feb;25(1):77-79. doi: 10.1017/S1431927618016173. Epub 2019 Feb 18.

PMID:
30773153
2.

Functional reorganization of marine fish nurseries under climate warming.

McLean MJ, Mouillot D, Goascoz N, Schlaich I, Auber A.

Glob Chang Biol. 2019 Feb;25(2):660-674. doi: 10.1111/gcb.14501. Epub 2018 Dec 1.

PMID:
30367735
3.

In-situ elastic strain mapping during micromechanical testing using EBSD.

McLean MJ, Osborn WA.

Ultramicroscopy. 2018 Feb;185:21-26. doi: 10.1016/j.ultramic.2017.11.007. Epub 2017 Nov 14.

PMID:
29161620
4.

Interpreting Incidentally Identified Variants in Genes Associated With Catecholaminergic Polymorphic Ventricular Tachycardia in a Large Cohort of Clinical Whole-Exome Genetic Test Referrals.

Landstrom AP, Dailey-Schwartz AL, Rosenfeld JA, Yang Y, McLean MJ, Miyake CY, Valdes SO, Fan Y, Allen HD, Penny DJ, Kim JJ.

Circ Arrhythm Electrophysiol. 2017 Apr;10(4). pii: e004742. doi: 10.1161/CIRCEP.116.004742.

5.
6.

Smart Electronic Laboratory Notebooks for the NIST Research Environment.

Gates RS, McLean MJ, Osborn WA.

J Res Natl Inst Stand Technol. 2015 Dec 2;120:293-303. doi: 10.6028/jres.120.018. eCollection 2015.

7.

Antiparasitic resistance and grazing livestock in the United States.

Kornele ML, McLean MJ, O'Brien AE, Phillippi-Taylor AM.

J Am Vet Med Assoc. 2014 May 1;244(9):1020-2. doi: 10.2460/javma.244.9.1020. No abstract available.

PMID:
24739108
8.

Male quality, signal reliability and female choice: assessing the expectations of inter-sexual selection.

McLean MJ, Bishop PJ, Nakagawa S.

J Evol Biol. 2012 Aug;25(8):1513-20. doi: 10.1111/j.1420-9101.2012.02533.x. Epub 2012 May 16.

9.

Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling.

Löscher W, Cole AJ, McLean MJ.

Neurotherapeutics. 2009 Apr;6(2):258-62. doi: 10.1016/j.nurt.2009.01.014. Review.

10.

Aphasic or amnesic status epilepticus detected on PET but not EEG.

Dong C, Sriram S, Delbeke D, Al-Kaylani M, Arain AM, Singh P, McLean MJ, Abou-Khalil B.

Epilepsia. 2009 Feb;50(2):251-5. doi: 10.1111/j.1528-1167.2008.01782.x. Epub 2008 Sep 17.

11.

Effects of a static magnetic field on audiogenic seizures in black Swiss mice.

McLean MJ, Engström S, Qinkun Z, Spankovich C, Polley DB.

Epilepsy Res. 2008 Aug;80(2-3):119-31. doi: 10.1016/j.eplepsyres.2008.03.022. Epub 2008 Jun 9. Erratum in: Epilepsy Res. 2009 Oct;86(2-3):239. Polley, Daniel [corrected to Polley, Daniel B].

PMID:
18541409
12.

Clinical features of epilepsy in patients with cerebellar structural abnormalities in a referral center.

Recio MV, Gallagher MJ, McLean MJ, Abou-Khalil B.

Epilepsy Res. 2007 Aug;76(1):1-5. Epub 2007 Jul 30.

PMID:
17664061
13.

Validation of MSAT: an instrument to measure medical students' self-assessed confidence in musculoskeletal examination skills.

Vivekananda-Schmidt P, Lewis M, Hassell AB, Coady D, Walker D, Kay L, McLean MJ, Haq I, Rahman A.

Med Educ. 2007 Apr;41(4):402-10.

PMID:
17430286
14.

Diabetic peripheral neuropathic pain: case studies.

Belgrade MJ, Cole BE, McCarberg BH, McLean MJ.

Mayo Clin Proc. 2006 Apr;81(4 Suppl):S26-32.

PMID:
16608050
15.

Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.

Argoff CE, Backonja MM, Belgrade MJ, Bennett GJ, Clark MR, Cole BE, Fishbain DA, Irving GA, McCarberg BH, McLean MJ.

Mayo Clin Proc. 2006 Apr;81(4 Suppl):S12-25. Review. Erratum in: Mayo Clin Proc. 2006 Jun;81(6):854.

PMID:
16608049
16.

Devices for gradient static magnetic field exposure.

Engström S, Markov MS, McLean MJ, Jones RA, Holcomb RR.

Bioelectromagnetics. 2005 May;26(4):336-40.

PMID:
15832330
17.

A static magnetic field modulates severity of audiogenic seizures and anticonvulsant effects of phenytoin in DBA/2 mice.

McLean MJ, Engström S, Holcomb RR, Sanchez D.

Epilepsy Res. 2003 Jun-Jul;55(1-2):105-16.

PMID:
12948620
18.

Gabapentin dosing in the treatment of epilepsy.

McLean MJ, Gidal BE.

Clin Ther. 2003 May;25(5):1382-406. Review.

PMID:
12867216
19.

Effects of non-uniform static magnetic fields on the rate of myosin phosphorylation.

Engström S, Markov MS, McLean MJ, Holcomb RR, Markov JM.

Bioelectromagnetics. 2002 Sep;23(6):475-9.

PMID:
12210566
20.

Two configurations of static magnetic fields for treating rheumatoid arthritis of the knee: a double-blind clinical trial.

Segal NA, Toda Y, Huston J, Saeki Y, Shimizu M, Fuchs H, Shimaoka Y, Holcomb R, McLean MJ.

Arch Phys Med Rehabil. 2001 Oct;82(10):1453-60.

PMID:
11588753
21.

Static magnetic field therapy for pain in the abdomen and genitals.

Holcomb RR, Worthington WB, McCullough BA, McLean MJ.

Pediatr Neurol. 2000 Sep;23(3):261-4.

PMID:
11033291
22.

Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group.

Morrell MJ, McLean MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus L, Bernstein P, Rose-Legatt.

Seizure. 2000 Jun;9(4):241-8.

23.
24.

Gabapentin in the management of convulsive disorders.

McLean MJ.

Epilepsia. 1999;40 Suppl 6:S39-50; discussion S73-4. Review.

25.

A single issue program in an isolated area: mammography screening in Darwin, NT.

McLean MJ, Condon JR.

Aust N Z J Public Health. 1999 Aug;23(4):357-61.

PMID:
10462857
26.

Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.

McLean MJ, Morrell MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus-Miller L, Bernstein P, Rose-Legatt A.

Epilepsia. 1999 Jul;40(7):965-72.

27.

Proteome composition and codon usage in spirochaetes: species-specific and DNA strand-specific mutational biases.

Lafay B, Lloyd AT, McLean MJ, Devine KM, Sharp PM, Wolfe KH.

Nucleic Acids Res. 1999 Apr 1;27(7):1642-9.

28.

Fatal familial insomnia: clinical and pathologic heterogeneity in genetic half brothers.

Johnson MD, Vnencak-Jones CL, McLean MJ.

Neurology. 1998 Dec;51(6):1715-7.

PMID:
9855529
29.

Base composition skews, replication orientation, and gene orientation in 12 prokaryote genomes.

McLean MJ, Wolfe KH, Devine KM.

J Mol Evol. 1998 Dec;47(6):691-6.

PMID:
9847411
30.

Trans-2-en-valproic acid limits action potential firing frequency in mouse central neurons in cell culture.

Wamil AW, Loscher W, McLean MJ.

J Pharmacol Exp Ther. 1997 Mar;280(3):1349-56.

PMID:
9067323
32.

Characteristics of triplex-directed photoadduct formation by psoralen-linked oligodeoxynucleotides.

Bates PJ, Macaulay VM, McLean MJ, Jenkins TC, Reszka AP, Laughton CA, Neidle S.

Nucleic Acids Res. 1995 Nov 11;23(21):4283-9.

33.

Inhibition of aromatase expression by a psoralen-linked triplex-forming oligonucleotide targeted to a coding sequence.

Macaulay VM, Bates PJ, McLean MJ, Rowlands MG, Jenkins TC, Ashworth A, Neidle S.

FEBS Lett. 1995 Sep 25;372(2-3):222-8.

34.

Regional distribution of protease-resistant prion protein in fatal familial insomnia.

Parchi P, Castellani R, Cortelli P, Montagna P, Chen SG, Petersen RB, Manetto V, Vnencak-Jones CL, McLean MJ, Sheller JR, et al.

Ann Neurol. 1995 Jul;38(1):21-9.

PMID:
7611720
35.

Gabapentin.

McLean MJ.

Epilepsia. 1995;36 Suppl 2:S73-86. Review.

PMID:
8784216
36.

Blockade of sensory neuron action potentials by a static magnetic field in the 10 mT range.

McLean MJ, Holcomb RR, Wamil AW, Pickett JD, Cavopol AV.

Bioelectromagnetics. 1995;16(1):20-32.

PMID:
7748200
37.

Measurement and analysis of static magnetic fields that block action potentials in cultured neurons.

Cavopol AV, Wamil AW, Holcomb RR, McLean MJ.

Bioelectromagnetics. 1995;16(3):197-206.

PMID:
7677796
38.

Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures.

Wamil AW, Schmutz M, Portet C, Feldmann KF, McLean MJ.

Eur J Pharmacol. 1994 Dec 27;271(2-3):301-8.

PMID:
7705430
39.

Acetazolamide for the treatment of chronic paroxysmal hemicrania.

Warner JS, Wamil AW, McLean MJ.

Headache. 1994 Nov-Dec;34(10):597-9.

PMID:
7843957
40.

Reagents for the preparation of two oligonucleotides per synthesis (TOPS).

Hardy PM, Holland D, Scott S, Garman AJ, Newton CR, McLean MJ.

Nucleic Acids Res. 1994 Aug 11;22(15):2998-3004.

41.

Clinical pharmacokinetics of gabapentin.

McLean MJ.

Neurology. 1994 Jun;44(6 Suppl 5):S17-22; discussion S31-2. Review.

PMID:
8022536
42.
43.

Oxcarbazepine: mechanisms of action.

McLean MJ, Schmutz M, Wamil AW, Olpe HR, Portet C, Feldmann KF.

Epilepsia. 1994;35 Suppl 3:S5-9. Review.

PMID:
8156978
44.

Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.

Schmutz M, Brugger F, Gentsch C, McLean MJ, Olpe HR.

Epilepsia. 1994;35 Suppl 5:S47-50.

PMID:
8039471
45.

Diethyl pyrocarbonate as a probe of protein-DNA interactions.

McLean MJ.

Methods Mol Biol. 1994;30:89-95. No abstract available.

PMID:
8004216
46.

Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons.

Wamil AW, McLean MJ.

J Pharmacol Exp Ther. 1993 Oct;267(1):218-27.

PMID:
8229748
47.

Antigen-driven B cell differentiation in vivo.

McHeyzer-Williams MG, McLean MJ, Lalor PA, Nossal GJ.

J Exp Med. 1993 Jul 1;178(1):295-307.

48.

Effect of environmental stress and surface treatment on resin-to-metal bonding.

Smith RM, Barrett MG, Gardner WA, Marshall T, McLean MJ, McMichael DW, Yerbury PJ, Rawls HR.

Am J Dent. 1993 Jun;6(3):111-5.

PMID:
8240769
49.

The production of PCR products with 5' single-stranded tails using primers that incorporate novel phosphoramidite intermediates.

Newton CR, Holland D, Heptinstall LE, Hodgson I, Edge MD, Markham AF, McLean MJ.

Nucleic Acids Res. 1993 Mar 11;21(5):1155-62.

50.

Supplemental Content

Loading ...
Support Center